UNSPSC 51372113: Codeine hydrochloride

This classification denotes an opiate with the molecular formula C18H21NO3.ClH.2H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier NTZ53GG7XN, chemically known as morphinan-6-alpha-ol, 7,8-didehydro-4,5-alpha-epoxy-3-methoxy-17-methyl-, hydrochloride but more generally known as codeine hydrochloride, which bears US NIH Compound Identifier 5359615. European Medicines Agency schedules Codeine hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01405MIG.

Most nations, for tariff and trade purposes, schedule codeine hydrochloride under HS 29391100. As of Q4 2014, CODEINE HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: CN1CC[C@]23C4C5CCC(C4O[C@H]2[C@H](C=C[C@H]3[C@H]1C5)O)OC.O.O.CL.

UNSPSC 51372113 Codeine hydrochloride, a Commodity code, appears in state and local procurement records with minimal recent activity. The single tracked recent opportunity—Seminole County, Florida's IFB60459723LAS posted June 30, 2026—is tagged to this code but solicits naloxone and drug deactivation systems for community health initiatives, not codeine products. This mismatch suggests the code shows little relevant recent activity in state and local procurement, or that the opportunity was miscoded at posting.

Seminole County's naloxone and drug deactivation systems procurement, due July 26, 2023, sought 1,900 units of naloxone and 800 safe drug deactivation systems annually through competitive bidding with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. The IFB required electronic submission through the county's e-Procurement Portal, E-Verify compliance, drug-free workplace certification, and standard insurance coverages; the contract was structured as a fixed-fee award with a two-year initial term plus one-year renewal option. No explicit set-aside designations were noted, and potential FEMA funding introduced additional federal compliance requirements. This single opportunity provides insufficient basis to characterize geographic concentration or issuing-body patterns under the codeine hydrochloride code.